A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19
The precise mechanisms of pathology in severe COVID-19 remains elusive. Current evidence suggests that inflammatory mediators are responsible for the manifestation of clinical symptoms that precedes a fatal response to infection. This review examines the nature of platelet activating factor and emph...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5edbd1c1c50a4406b493905b9187d87f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:5edbd1c1c50a4406b493905b9187d87f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:5edbd1c1c50a4406b493905b9187d87f2021-11-11T00:33:25ZA Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-191938-272310.1177/10760296211051764https://doaj.org/article/5edbd1c1c50a4406b493905b9187d87f2021-11-01T00:00:00Zhttps://doi.org/10.1177/10760296211051764https://doaj.org/toc/1938-2723The precise mechanisms of pathology in severe COVID-19 remains elusive. Current evidence suggests that inflammatory mediators are responsible for the manifestation of clinical symptoms that precedes a fatal response to infection. This review examines the nature of platelet activating factor and emphasizes the similarities between the physiological effects of platelet activating factor and the clinical complications of severe COVID-19.Mark Klein MDVinh Dao PharmD, BCPSFatima Khan MD, MPHSAGE PublishingarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENClinical and Applied Thrombosis/Hemostasis, Vol 27 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Diseases of the circulatory (Cardiovascular) system RC666-701 |
spellingShingle |
Diseases of the circulatory (Cardiovascular) system RC666-701 Mark Klein MD Vinh Dao PharmD, BCPS Fatima Khan MD, MPH A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 |
description |
The precise mechanisms of pathology in severe COVID-19 remains elusive. Current evidence suggests that inflammatory mediators are responsible for the manifestation of clinical symptoms that precedes a fatal response to infection. This review examines the nature of platelet activating factor and emphasizes the similarities between the physiological effects of platelet activating factor and the clinical complications of severe COVID-19. |
format |
article |
author |
Mark Klein MD Vinh Dao PharmD, BCPS Fatima Khan MD, MPH |
author_facet |
Mark Klein MD Vinh Dao PharmD, BCPS Fatima Khan MD, MPH |
author_sort |
Mark Klein MD |
title |
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 |
title_short |
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 |
title_full |
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 |
title_fullStr |
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 |
title_full_unstemmed |
A Review of Platelet-Activating Factor As a Potential Contributor to Morbidity and Mortality Associated with Severe COVID-19 |
title_sort |
review of platelet-activating factor as a potential contributor to morbidity and mortality associated with severe covid-19 |
publisher |
SAGE Publishing |
publishDate |
2021 |
url |
https://doaj.org/article/5edbd1c1c50a4406b493905b9187d87f |
work_keys_str_mv |
AT markkleinmd areviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19 AT vinhdaopharmdbcps areviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19 AT fatimakhanmdmph areviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19 AT markkleinmd reviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19 AT vinhdaopharmdbcps reviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19 AT fatimakhanmdmph reviewofplateletactivatingfactorasapotentialcontributortomorbidityandmortalityassociatedwithseverecovid19 |
_version_ |
1718439587874865152 |